Multi-step protein purification technique for crystallization by Pope, Albryona (Author) & All works in this collection either are protected by copyright or are the property of the Robert W. Woodruff Library, and/or the copyright holder as appropriate. To order a reproduction or to inquire about permission to publish, please contact Holly Smith, College Archivist at: hsmith12@spelman.edu with the web URL or handle identification number. (Copyright claimant)




For years crystallization has been used to understand and identify the
molecular structure of proteins. In order to obtain the best and most useful
crystals from a particular protein and to properly identify its structure, it is
necessary to purify the protein. The goal of this work is to develop a multi-
step purification technique for the purification of two specific proteins, mGO,
modified glycolate oxidase, and SL06. This purification aims to isolate the
protein from a complex mixture. Each protein is expressed in bacteria, His-
Tagged, sonicated, and dialyzed in order to purify. SL06 is a dimeric receptor
protein that is involved in the stress response of a tomato. When exposed to
abscisic acid, a hormone known to induce plant stress, SL06 forms a complex
and is known to exhibit differences in crystal structure. By identifying the
crystal structure of SL06 and SL06-ABA complexes, the differences and
similarities between the two structures can be examined. mGO, also known
as modified glycolate oxidase, is a protein involved in the production of
glyoxylate and subsequently oxalate in humans. In people who suffer from
hyperoxaluria type 1, AGXT, enzyme acting in the breakdown of oxalate is
defective and causes a buildup in oxalate. When mGO reacts with a ligand,
CCPST, the crystal structure of mGO is altered and oxalate production is
inhibited. By examining the structures of mGO and mGO-CCPST, scientist
can identify conformational changes that may aid in the treatment of
hyperoxaluria. The use of this simplified multistep process aided in the
crystallization process by producing a higher concentration of protein.
ABSTRACT
Primary hyperaluria type 1 (PH1) is a rare autosomal recessive disorder of
one’s metabolism that is caused by a functional deficiency of the pyridoxal-
phosphate-dependent enzyme alanine:glyoxylate aminotransferase (AGXT) ,
which is liver specific. Within the peroxisomes of normal hepatocytes, AGXT
catalyzes the transamination of the intermediate glyoxylate to glycine. PH1
often occurs when AGT mistargets and allows glycoxylate (GO) to escape
from the perzxisomes into the cytosol, where it oxidizes to oxalate, a reaction
which is catalyzed by lactate dehydrogenase (LDH). The newly formed
oxalate is reduced to glycolate, catalyzed by glyoxylate/hydroxypyruvate
reductase (Figure 1) In humans oxalates is unable to be further metabolized,
and its increased synthesis leads primarily to the accumulation of insoluble
calcium oxide (CaOx) in places like the urinary tract and kidneys, which can
lead to unbearable pain and eventually, this leads to renal failure. For years
there have been attempts to develop treatment for those suffering from PH1.
Most of these treatments have been aimed at correcting of AGT mistargeting.
Two main pharmacological strategies have been suggested to ameliorate the
symptoms. AGXT is the first target, and the strategy is based on find
compounds that rescue its activity or avoid its mistargeting. Second strategy
aims to inhibit the activity of GO to reduce the levels of the free glyoxylate
and hence to reduce the oxalate formation. SL06 is a dimeric receptor protein
that is involved in the stress response of a tomato. When exposed to abscisic
acid, a hormone known to induce plant stress, SL06 forms a complex and is
known to exhibit differences in crystal structure. By identifying the crystal
structure of SL06 and SL06-ABA complexes, the differences and similarities
between the two structures can be examined.
INTRODUCTION
TRANSFORMATION
Transform expression plasmid into BL21 (DE3)and plate in LBA (Amp) plates overnight
Growth and induction
Start 10 mL starter flask for overnight culutre in 2TY 100 microliters of Amp. Dilute
culture 1:100 into 1000 mL 2TY, 100 uL/mL, incubate for approximately 1-2 hours in 37 C.
Allow growth to reach an optical density of approximately 0.6 -0.7 at absorbance of 600
nm, add IPTG 0.2 mM and transfer to 16 C incubator for overnight growth
Protein Purifcation
Pellet cells at 4500 rpm for 15 minutes, Resuspend cells in 25-30 mL of cold lysis buffer
(50 mM NaCl, 50 mM imidazole, 50 mM Tris HCl pH 8.5)
Sonicate 9x10” with 10” intervals at maximum amplitude
Centrifuge for 45 minutes at 17000 rpm
Remove and save supernatant
Wash HisTrap column with 5 volumes of H20 and 5 volumes of lysis buffer (50 mM
TrisHCl, 50 mM NaCl, 50 mM imidazole)
Run supernatant through column and wash with 5 volumes of lysis buffer
Pass elution buffer through the column and collect
MATERIALS AND METHODS
•The multi-step purification technique provided optimal
optical density for each protein tested.
•mGO protein crystallized but not defracted
•Future research will be done to finalize structure of each
protein
CONCLUSIONS
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Figure. 1. A.) Mechanism for the production of calcium oxalate in side a human cell.
Metabolic consequences of peroxisomal AGXT deficiency in PH1. AGT (AGXT),
alanine:glyoxlate aminotransferase; LDH, lactate dehydrogenase; GR,
glyoxylate/hydroxypyruvate reductase. Solid lines represent metabolic conversion; dotted
lines represent membrane or other transport.
Figure 2. B.)Mechanism for the production of ABA bound SL06, in both the monomeric and
dimeric states. ABA, abscisic acid (plant hormone); PP2C, protein phosphatase 2C.
Figure 4. Detection of purified mGO and Sl06 with Western Blotting Kit/
Electrophoresis.
Figure 3. Example of mGO protein. Crystals were obtained using a standard screening
plate
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